← Back to Screener
Impact BioMedical, Inc. (IBO)
Price$0.55
Value ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-0.37%
Price vs S&P 500 (4W)-25.82%
VGM Score34.20
Market Capitalization$56.07M
All Metrics
Book Value / Share (Quarterly)$0.11
Cash Flow / Share (Quarterly)$-0.02
Price vs S&P 500 (YTD)-7.96%
Net Profit Margin (TTM)-32969.23%
EPS (TTM)$-1.26
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-1.26
EPS (Annual)$-0.38
ROI (Annual)-89.48%
Gross Margin (Annual)84.38%
Cash / Share (Quarterly)$0.00
ROA (Last FY)-68.01%
EBITD / Share (TTM)$-0.08
ROE (5Y Avg)-143.73%
Operating Margin (TTM)-14256.41%
Cash Flow / Share (Annual)$-0.02
P/B Ratio4.89x
P/B Ratio (Quarterly)5.64x
Net Income / Employee (Annual)$-5,919,000
EV / Revenue (TTM)1465.38x
Net Interest Coverage (TTM)-0.42x
ROA (TTM)-71.67%
EPS Incl Extra (Annual)$-0.38
Current Ratio (Annual)0.35x
Quick Ratio (Quarterly)0.13x
3-Month Avg Trading Volume3.03M
52-Week Price Return6.12%
Revenue / Employee (TTM)$19,500
Tangible BV / Share (Quarterly)$1.15
P/S Ratio (Annual)1752.10x
Asset Turnover (Annual)0.00x
52-Week High$1.95
EPS Excl Extra (Annual)$-0.38
26-Week Price Return15.56%
Quick Ratio (Annual)0.18x
13-Week Price Return19.54%
Total Debt / Equity (Annual)0.05x
Current Ratio (Quarterly)0.22x
Enterprise Value$57.15M
Asset Turnover (TTM)0.00x
Revenue / Employee (Annual)$16,000
Pretax Margin (Annual)-45156.25%
Cash / Share (Annual)$0.00
3-Month Return Std Dev190.00%
Net Income / Employee (TTM)$-6,429,000
ROE (Last FY)-93.89%
Net Interest Coverage (Annual)-1.97x
EPS Basic Excl Extra (Annual)$-0.38
Receivables Turnover (TTM)19.50x
Total Debt / Equity (Quarterly)0.10x
EPS Incl Extra (TTM)$-1.26
ROI (TTM)22.93%
P/S Ratio (TTM)1437.62x
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-22.08%
Year-to-Date Return2.97%
5-Day Price Return-4.38%
EPS Normalized (Annual)$-0.38
ROA (5Y Avg)-43.39%
Net Profit Margin (Annual)-36993.75%
Month-to-Date Return-23.53%
EBITD / Share (Annual)$-0.10
Operating Margin (Annual)-13381.25%
ROI (5Y Avg)-61.93%
LT Debt / Equity (Quarterly)0.25x
EPS Basic Excl Extra (TTM)$-1.26
P/TBV (Quarterly)1.73x
P/B Ratio (Annual)0.49x
Pretax Margin (TTM)-39630.77%
Book Value / Share (Annual)$0.12
Price vs S&P 500 (13W)9.79%
Beta1.36x
Revenue / Share (TTM)$0.00
ROE (TTM)24.58%
52-Week Low$0.36
vGradeF
mGradeC
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IBOImpact BioMedical, Inc. | F | — | C | $0.55 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Impact BioMedical Inc develops therapeutics and preventative solutions targeting neurological, oncological, and immune-related diseases. The company also advances open-air defense technologies designed to reduce transmission of airborne infectious diseases, including tuberculosis and influenza. Its proprietary platforms include Linebacker, Laetose, 3F, and Equivir.